LOVENOX

This brand name is authorized in Austria, Canada, Germany, France, Tunisia, United States

Active ingredients

The drug LOVENOX contains one active pharmaceutical ingredient (API):

1 Enoxaparin UNII 8NZ41MIK1O - ENOXAPARIN SODIUM

Enoxaparin is a LMWH with a mean molecular weight of approximately 4,500 daltons, in which the antithrombotic and anticoagulant activities of standard heparin have been dissociated. The drug substance is the sodium salt and has a high anti-Xa activity. Read about Enoxaparin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LOVENOX Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AB05	Enoxaparin	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AB Heparin group
Discover more medicines within B01AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02012472, 02236564, 02236883, 02242692, 02378426, 02378434, 02378442, 02378469
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00393991
Country: FR	Base de données publique des médicaments	Identifier(s): 60755562, 60782303, 61937233, 64389824, 67010731, 67118995, 67464342, 67753717
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6113031, 6113032, 62130310, 6213033, 6213034, 6213037, 6213038, 6213039
Country: US	FDA, National Drug Code	Identifier(s): 0075-0620, 0075-0621, 0075-0622, 0075-0623, 0075-0624, 0075-0626, 0075-2912, 0075-2915, 0075-8013, 0075-8014, 0075-8016, 0075-8018, 0075-8020, 0075-8022, 0075-8025, 0075-8030, 55154-4028